Post-Report: Method for Estimating Stroke Risk Using Gut Microbiota Data Announced. Importance of "Data-Driven Preventive Medicine" Promoted by PMG Becomes Clear.
PMG Group announces research on estimating stroke risk from gut microbiota, presented at STROKE2026, highlighting data-driven preventive medicine and the "kenchonavi" service.
📋 Article Processing Timeline
- 📰 Published: April 10, 2026 at 22:00
- 🔍 Collected: April 11, 2026 at 00:23 (2h 23m after Published)
- 🤖 AI Analyzed: April 20, 2026 at 04:07 (219h 43m after Collected)
PMG Group (PMG Holdings Corporation, PMG Corporation, PMG Partners Corporation, PMG Logistics Corporation, PMGMA Partners Corporation) is pleased to announce that its strategic partner in corporate health management, Symbiosis Solutions Corporation, presented the latest research findings on gut flora and stroke risk at "STROKE2026 (Annual Meeting of the Japanese Society of Stroke)."
Experts from the National Cardiovascular Center and the National Center for Geriatrics and Gerontology presented evidence directly linking gut microbiota analysis to the prevention of serious diseases.
We support this knowledge and will promote its social implementation as an important trend backing the utility of our in-house gut microbiota testing service, "kenchonavi."
## ■Why is the PMG Group focusing on and disseminating information about this academic seminar?
PMG Group makes "knowing risks before illness strikes and preventing them" a pillar of its corporate health management.
Within this framework, we prioritize the visualization of the "gut environment," which influences overall health, and were among the first to introduce Symbiosis Solutions Corporation's technology.
The presentation at "STROKE2026," co-hosted by Symbiosis Solutions Corporation, demonstrated the potential to estimate specific disease risks like "stroke" from the state of the gut environment.
As a pioneer among adopting companies, we will leverage this cutting-edge medical knowledge...
Experts from the National Cardiovascular Center and the National Center for Geriatrics and Gerontology presented evidence directly linking gut microbiota analysis to the prevention of serious diseases.
We support this knowledge and will promote its social implementation as an important trend backing the utility of our in-house gut microbiota testing service, "kenchonavi."
## ■Why is the PMG Group focusing on and disseminating information about this academic seminar?
PMG Group makes "knowing risks before illness strikes and preventing them" a pillar of its corporate health management.
Within this framework, we prioritize the visualization of the "gut environment," which influences overall health, and were among the first to introduce Symbiosis Solutions Corporation's technology.
The presentation at "STROKE2026," co-hosted by Symbiosis Solutions Corporation, demonstrated the potential to estimate specific disease risks like "stroke" from the state of the gut environment.
As a pioneer among adopting companies, we will leverage this cutting-edge medical knowledge...